Omeros (NASDAQ:OMER – Get Free Report) and Guided Therapeutics (OTCMKTS:GTHP – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? Get Omeros alerts:ProfitabilityThis table compares Omeros and Guided Therapeutics’ net margins, return on equity and return on assets. Net Margins Return on Equity Return on Assets Omeros N/A -102.16% 64.87% Guided Therapeutics N/A N/A -274.24%Analyst RecommendationsSell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omeros 1 2 2 1 2.50 Guided Therapeutics 0 0 0 0 0.00This is a summary of recent ratings and target prices for Omeros and Guided Therapeutics, as reported by MarketBeat.com. Given Omeros’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Omeros is more favorable than Guided Therapeutics. Comparatively, Guided Therapeutics has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.